About this episode

This episode discusses a head to head study comparing romosozumab and teriparatide for managing osteoporosis.

Quick podcast this week about a nifty head to head study that I had previously missed. Worth reading if - like me - you're still trying to figure out how the heck to manage osteoporosis. Paper: https://pubmed.ncbi.nlm.nih.gov/28755782/

More episodes of The Evidence Based Rheumatology Podcast

• E134: Brepocitinib in Dermatomyositis (VALOR) · April 17, 2026 · 15 min
• E133: Obinutuzumab for SLE (ALLEGORY) · March 19, 2026 · 15 min
• E131: A Sham-Controlled Sham of a Trial: RESET-RA · January 21, 2026 · 15 min
• E130: Telitacicept for SLE · December 22, 2025 · 13 min
• E129: Long Term Routine Laboratory Monitoring in RA · December 4, 2025 · 15 min
• E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD) · November 12, 2025 · 19 min

Explore listener stats, chart rankings, contacts and more on the The Evidence Based Rheumatology Podcast podcast page.